Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.
Hassell TJW, Charles D.
Toxins (Basel). 2020 Apr 22;12(4):269. doi: 10.3390/toxins12040269.
Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update.
Ma H, Qu J, Ye L, Shu Y, Qu Q.
Front Neurol. 2021 Mar 29;12:630221. doi: 10.3389/fneur.2021.630221. eCollection 2021.
Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
Karp BI, Alter K.
Semin Neurol. 2016 Feb;36(1):84-91. doi: 10.1055/s-0036-1571952. Epub 2016 Feb 11.
Atypical Blepharospasm with Oromandibular Dystonia Associated with Cerebral Amyloid Angiopathy.
Carey AR, Miller NR.
Neuroophthalmology. 2021 Aug 10;46(3):178-181. doi: 10.1080/01658107.2021.1958871. eCollection 2022.
Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R, Cardoso F, Truong DD.
Eur J Neurol. 2006 Feb;13 Suppl 1:21-9. doi: 10.1111/j.1468-1331.2006.01441.x.
Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
Tolosa E, Martí MJ.
Adv Neurol. 1988;49:73-84.
Progressive thalamic nuclear atrophy in blepharospasm and blepharospasm-oromandibular dystonia.
Xu J, Luo Y, Zhang J, Zhong L, Liu H, Weng A, Yang Z, Zhang Y, Ou Z, Yan Z, Cheng Q, Fan X, Zhang X, Zhang W, Hu Q, Liang D, Peng K, Liu G.
Brain Commun. 2024 Apr 8;6(2):fcae117. doi: 10.1093/braincomms/fcae117. eCollection 2024.
Posttraumatic dystonia.
Frei K.
J Neurol Sci. 2017 Aug 15;379:183-191. doi: 10.1016/j.jns.2017.05.040. Epub 2017 May 23.
Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome).
Klawans HL, Tanner CM.
Adv Neurol. 1988;49:443-50.
Meige Syndrome.
Zeppieri M, Ameer MA, Jahngir MU, Patel BC.
2024 May 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
